Leflunomide ratiopharm
leflunomide
leflunomide
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, pharmacist or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What Leflunomide ratiopharm is and what it is used for
What you need to know before you take Leflunomide ratiopharm
How to take Leflunomide ratiopharm
Possible side effects
How to store Leflunomide ratiopharm
Contents of the pack and other information
Leflunomide ratiopharm contains the active substance leflunomide which belongs to a group of medicines called anti-rheumatic medicines.
Leflunomide ratiopharm is used to treat adult patients with active rheumatoid arthritis or with active psoriatic arthritis.
Symptoms of rheumatoid arthritis include inflammation of joints, swelling, difficulty moving and pain. Other symptoms that affect the entire body include loss of appetite, fever, loss of energy and anaemia (lack of red blood cells).
Symptoms of active psoriatic arthritis include inflammation of joints, swelling, difficulty moving, pain and patches of red, scaly skin (skin lesions).
if you have ever had an allergic reaction to leflunomide (especially a serious skin reaction, often accompanied by fever, joint pain, red skin stains, or blisters e.g. Stevens-Johnson syndrome), to peanut or soya or to any of the other ingredients of this medicine (listed in section 6), or if you are allergic to teriflunomide (used to treat multiple sclerosis),
if you have any liver problems,
if you have moderate to severe kidney problems,
if you have severely low numbers of proteins in your blood (hypoproteinaemia),
if you suffer from any problem which affects your immune system (e.g. AIDS),
if you have any problem with your bone marrow, or if you have low numbers of red or white cells in your blood or a reduced number of blood platelets,
if you are suffering from a serious infection,
if you are pregnant, think you may be pregnant, or are breast-feeding.
Talk to your doctor, pharmacist or nurse before taking Leflunomide ratiopharm
if you have ever suffered from inflammation of the lung (interstitial lung disease).
if you have ever had tuberculosis or if you have been in close contact with someone who has or has had tuberculosis. Your doctor may perform tests to see if you have tuberculosis.
if you are male and wish to father a child. As it can not be excluded that Leflunomide ratiopharm passes into semen, reliable contraception should be used during treatment with Leflunomide ratiopharm. Men wishing to father a child should contact their doctor who may advise them to stop taking Leflunomide ratiopharm and take certain medicines to remove Leflunomide ratiopharm rapidly and sufficiently from their body. You will then need a blood test to make sure that Leflunomide ratiopharm has been sufficiently removed from your body, and you should then wait for at least another 3 months before attempting to father a child.
if you are due to have a specific blood test (calcium level). Falsely low levels of calcium can be detected.
Leflunomide ratiopharm can occasionally cause some problems with your blood, liver, lungs or nerves in your arms or legs. It may also cause some serious allergic reactions (including Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]), or increase the chance of a severe infection. For more information on these, please read section 4 (Possible side effects).
DRESS appears initially as flu-like symptoms and a rash on the face then an extended rash with a high temperature, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes.
Your doctor will carry out blood tests at regular intervals, before and during treatment with Leflunomide ratiopharm, to monitor your blood cells and liver. Your doctor will also check your blood pressure regularly as Leflunomide ratiopharm can cause an increase in blood pressure.
Tell your doctor if you have unexplained chronic diarrhoea. Your doctor may perform additional tests for differential diagnosis.
Tell your doctor if you develop skin ulcer during treatment with Leflunomide ratiopharm (see also section 4).
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription.
This is especially important if you are taking:
other medicines for rheumatoid arthritis such as antimalarials (e.g. chloroquine and hydroxychloroquine), intramuscular or oral gold, D-penicillamine, azathioprine and other immunosuppressive medicines (e.g. methotrexate) as these combinations are not advisable,
warfarin and other oral medicines used to thin the blood, as monitoring is necessary to reduce the risk of side effects of this medicine
teriflunomide for multiple sclerosis
repaglinide, pioglitazone, nateglinide, or rosiglitazone for diabetes
daunorubicin, doxorubicin, paclitaxel, or topotecan for cancer
duloxetine for depression, urinary incontinence or in kidney disease in diabetics
alosetron for the management of severe diarrhoea
theophylline for asthma
tizanidine, a muscle relaxant
oral contraceptives (containing ethinylestradiol and levonorgestrel)
cefaclor, benzylpenicillin (penicillin G), ciprofloxacin for infections
indomethacin, ketoprofen for pain or inflammation
furosemide for heart disease (diuretic, water pill)
zidovudine for HIV infection
rosuvastatin, simvastatin, atorvastatin, pravastatin for hypercholesterolemia (high cholesterol)
sulfasalazine for inflammatory bowel disease or rheumatoid arthritis
If you are already taking a nonsteroidal anti-inflammatory drug (NSAID) and/or corticosteroids, you may continue to take them after starting Leflunomide ratiopharm.
If you have to be vaccinated, ask your doctor for advice. Certain vaccinations should not be given while taking Leflunomide ratiopharm, and for a certain amount of time after stopping treatment.
Leflunomide ratiopharm may be taken with or without food.
It is not recommended to drink alcohol during treatment with Leflunomide ratiopharm. Drinking alcohol while taking Leflunomide ratiopharm may increase the chance of liver damage.
Tell your doctor if you plan to become pregnant after stopping treatment with Leflunomide ratiopharm, as you need to ensure that all traces of Leflunomide ratiopharm have left your body before trying to become pregnant. This may take up to 2 years. This may be reduced to a few weeks by taking certain medicines which speed up removal of Leflunomide ratiopharm from your body.
In either case it should be confirmed by a blood test that Leflunomide ratiopharm has been sufficiently removed from your body and you should then wait for at least another month before you become pregnant.
For further information on the laboratory testing please contact your doctor.
If you suspect that you are pregnant while taking Leflunomide ratiopharm or in the two years after you have stopped treatment, you must contact your doctor immediately for a pregnancy test. If the test confirms that you are pregnant, your doctor may suggest treatment with certain medicines to remove Leflunomide ratiopharm rapidly and sufficiently from your body, as this may decrease the risk to your baby.
Leflunomide ratiopharm can make you feel dizzy which may impair your ability to concentrate and react. If you are affected, do not drive, or use machines.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially ‘sodium-free’.
If you are allergic to peanut or soya, do not use this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The usual starting dose of Leflunomide ratiopharm is 100 mg once daily for the first three days. After this, most patients need a dose of:
For rheumatoid arthritis: 10 or 20 mg Leflunomide ratiopharm once daily, depending on the severity of the disease.
For psoriatic arthritis: 20 mg Leflunomide ratiopharm once daily.
It may take about 4 weeks or longer until you start to feel an improvement in your condition. Some patients may even still feel further improvements after 4 to 6 months of therapy.
You will normally take Leflunomide ratiopharm over long periods of time.
If you take more Leflunomide ratiopharm than you should, contact your doctor or get other medical advice. If possible, take your tablets or the box with you to show the doctor.
If you forget to take a dose, take it as soon as you remember, unless it is nearly time for your next dose. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Tell your doctor immediately and stop taking Leflunomide ratiopharm:
if you experience weakness, feel light-headed or dizzy or have difficulty breathing, as these may be signs of a serious allergic reaction,
if you develop a skin rash or ulcers in your mouth, as these may indicate severe, sometimes life-threatening reactions (e.g. Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]), see section 2.
Tell your doctor immediately if you experience:
any symptoms of an infection such as fever, sore throat or cough, as this medicine may increase the chance of a severe infection which may be life-threatening,
unusual tingling, weakness or pain in your hands or feet as these may indicate problems with your nerves (peripheral neuropathy).
a slight decrease in the number of white blood cells (leucopenia),
mild allergic reactions,
loss of appetite, weight loss (usually insignificant),
tiredness (asthenia),
headache, dizziness,
abnormal skin sensations like tingling (paraesthesia),
mild increase in blood pressure,
colitis,
diarrhoea,
nausea, vomiting,
inflammation of the mouth or mouth ulcers,
abdominal pain,
an increase in some liver test results,
increased hair loss,
eczema, dry skin, rash, itching,
tendonitis (pain caused by inflammation in the membrane surrounding the tendons usually in the feet or hands),
an increase of certain enzymes in the blood (creatine phosphokinase),
problems in the nerves of the arms or legs (peripheral neuropathy).
a decrease in the number of red blood cells (anaemia) and a decrease in the number of blood platelets (thrombocytopenia),
a decrease in the levels of potassium in the blood,
anxiety,
taste disturbances,
urticaria (nettle rash),
tendon rupture,
an increase in the levels of fat in the blood (cholesterol and triglycerides),
a decrease in the levels of phosphate in the blood.
an increase in the numbers of blood cells called eosinophiles (eosinophilia); mild decrease in the number of white blood cells (leucopenia); decrease in the number of all blood cells (pancytopenia),
severe increase in blood pressure,
inflammation of the lung (interstitial lung disease),
an increase in some liver results which may develop into serious conditions such as hepatitis and jaundice,
severe infections called sepsis which may be fatal,
an increase of certain enzymes in the blood (lactate dehydrogenase).
a marked decrease of some white blood cells (agranulocytosis),
severe and potentially severe allergic reactions,
inflammation of blood vessels (vasculitis, including cutaneous necrotizing vasculitis),
inflammation of the pancreas (pancreatitis),
severe liver injury such as liver failure or necrosis which may be fatal,
severe sometimes life-threatening reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme).
Other side effects such as kidney failure, a decrease in the levels of uric acid in your blood, pulmonary hypertension, male infertility (which is reversible once treatment with this medicine is stopped), cutaneous lupus (characterized by rash/erythema on skin areas that are exposed to light), psoriasis (new or worsening) DRESS and Skin ulcer (Round, open sore in the skin through which the underlying tissues can be seen), may also occur with a not known frequency.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer carton and on the bottle after EXP. The expiry date refers to the last day of that month.
Keep the bottle tightly closed in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is leflunomide.
One film-coated tablet contains 10 mg of leflunomide.
The other ingredients are lactose monohydrate, low-substituted hydroxypropyl cellulose, tartaric acid, sodium laurylsulfate and magnesium stearate in the tablet core as well as lecithin (soybeans), poly(vinyl alcohol), talc, titanium dioxide (E171) and xanthan gum in the film- coating.
Leflunomide ratiopharm 10 mg film-coated tablets are white to almost white and round with a diameter of about 6 mm.
The tablets are packed in bottles.
Pack sizes of 30 and 100 film-coated tablets per bottle are available. Not all pack size may be marketed.
ratiopharm GmbH Graf-Arco-Straße 3
89079 Ulm
Germany
Haupt Pharma Münster GmbH Schleebrüggenkamp 15
48159 Münster Germany
Merckle GmbH
Ludwig-Merckle-Straße 3
89143 Blaubeuren Germany
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373
UAB Teva Baltics Tel: +370 52660203
Тева Фарма ЕАД Teл: +359 24899585
Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111
Teva Gyógyszergyár Zrt. Tel: +36 12886400
Teva Denmark A/S Tlf: +45 44985511
Teva Pharmaceuticals Ireland L-Irlanda
Tel: +44 2075407117
Teva Nederland B.V. Tel: +31 8000228400
UAB Teva Baltics Eesti filiaal Tel: +372 6610801
Teva Norway AS Tlf: +47 66775590
Specifar A.B.E.E.
Τηλ: +30 2118805000
ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070
Teva Pharma, S.L.U. Tél: +34 913873280
Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300
Teva Santé
Tél: +33 155917800
ratiopharm - Comércio e Industria de Produtos Farmacêuticos, Lda.
Tel: +351 214767550
Pliva Hrvatska d.o.o. Tel: +385 13720000
Teva Pharmaceuticals S.R.L. Tel: +40 212306524
Teva Pharmaceuticals Ireland Tel: +44 2075407117
Pliva Ljubljana d.o.o. Tel: +386 15890390
Teva Pharma Iceland ehf. Sími: +354 5503300
TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911
Teva Italia S.r.l.
Teva Finland Oy
Tel: +39 028917981 Puh/Tel: +358 201805900
Specifar A.B.E.E.
Ελλάδα
Τηλ: +30 2118805000
Teva Sweden AB Tel: +46 42121100
UAB Teva Baltics filiāle Latvijā
Tel: +371 67323666
Teva Pharmaceuticals Ireland Ireland
Tel: +44 2075407117